begin afternoon, colleagues Larry, work during thank like thanking things for started, the to Mirion I'd you, and their good very by get quarter. To hard everyone. second my
from with highlights the get results, Let's details our around into beginning some the quarter. right
growth. of QX last another order quarter. our period quarter same First, growth the was X% backlog approximately We year expanded consecutive for the booked adjusted position to fourth order solid compared and
Importantly, of projects. smaller have on strength engagement we to recurring and continue larger Technologies customers degree a see from high
for the revenue with delivering of over growth same nearly year. organic compared the group Second, company X.X% quarter, Technologies to for way we last X%. the growth expectations internal The our led organic outpaced total of period
quarter. Third, was the $X.X free million cash in flow second
net quarter challenged the for expense admittedly it both is by Cash and and higher with the this interest our working for was consistent the dynamics While capital a expectations meager year. sum, was flow quarter.
adjusted and new our previous and XXXX. bringing guidance updated raised range. revenue increased the towards end of our our expectations, our we've EBITDA have upper tightened for financial the Finally, midpoint We ranges
million $XX for to year. guidance $XX the to of million flow updated We also adjusted full free the cash range
generation our our order approvals driven prepare some we procedural growth by of dosimetry, industrials, quality Medical by growth has diversified segment, center. end strategy driven assurance see results, radiopharmaceutical first therapy Instadose nuclear markets. to X, we within half stable seeing Now in third we in diagnostic comps from see defense continue to with order medicine, the market patient orders If growth financial we Radiation technology positive highlight and tough to trends like results volume. our quarterly delving including and continue investment our I'd research, the turn half And before into In and the performance and launch marketing performance our our X%, new customer we're Slide our strength. robust, and first and and engagement national we labs to digital been was finally, to from macro strong within and by year-over-year XXXX. to medicine In power both nuclear offset businesses. tailwinds, nuclear account sales of in growing good platform as therapeutic continue our enjoy European the
the encouraged well. as we In dynamics Technologies segment, by remain market
expectations XX% growth base, with year, is segment the in In last beyond. installed the see order also coming the strong comps and with first coupled European tough. second favorable, order over notable half first As and contributions business, were nuclear the in performance were and space first strengthening the from cadence. markets. half new our defense American power lab build dialogue for to and so a labs delivered Overall, our within half, demand in reminder, half a we we we defense the improving Both support strong North environment expect
flip our Slide second X quarter to Let's detail. discuss in results to more now over
X.X% noted, organic both previously on second revenue the consolidated delivered segments. by As in solid we organic basis supported in growth almost a growth quarter
added we CIRS domestic was side, with our within phantoms assurance market Performance the continued Sun by Medical radiation in business. therapy quality organic internationally quarter. growth Nuclear legacy both the a end spurred the X% in during strength businesses and the revenue nearly growth demand in delivered slowdown encouraging the and recent offsetting momentum On
performance here revenue was strong Technologies Segment Additionally, over growth. for the QX products. X% and was positive as across delivered we geographies segment organic
Brian to couple I'd A make before on. of final highlights jumps like
to on flow cash we year, the opportunity second inventory at and First, a to cash my margins. lies operational the On very free primary transition the of of top both is half clear flow, improve turns. as our agenda with excellence focus
the frequent supply to to directed mitigant During dislocation, often and we reserves inventory and the organization chain as the up a I build unpredictable pandemic subsequent global strategic supplier experienced. de-commits
Now across we base see can stability and to footing off our war supply greater a degree. this significant come
process Consequently, from industrial bolstered we as an both capabilities our a have as well organizational standpoint. planning
production turns is group in improvements of Our to and distribution planning. near-term teams tiger drive to aggressively, organized planning, Xx. goal drive we've And our median to this roughly get to after peer inventory scheduling demand
not a impact company been back integration in to results the progress SIS we've making lapped numbers, reflected costs, half to stable of our public company confident I'm year. of and have will expect planning horizon. compression as see the the yet the is Public meaningful transitory be within cost on impact great seen incremental now result margins, our While of margin On we in and backlog. are down. the SIS the our costs effects it neutral of price We're and the integration
a it into and taken the aggressive backlog beginning simultaneously labor greater of reduction inputs. to seeing in through realization XXXX turn in flows inflationary action the see material we're price as while rates price Finally,
is in ahead. the that this our quarters my expansion of of reflective margin view continue and long we of years will All history
over Brian? Brian mic now our pass Officer, to me the Chief Schopfer. Let Financial